Common Contracts
4 similar At Market Issuance Sales Agreement contracts by Antigenics Inc /De/, ExOne Co, Omeros Corp, pSivida Corp.
THE EXONE COMPANY Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • January 11th, 2016 • ExOne Co • Printing trades machinery & equipment • New York
The ExOne Company, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with FBR Capital Markets & Co. (“FBR”) and MLV & Co. LLC (“MLV”, each of FBR and MLV individually a “Distribution Agent” and collectively the “Distribution Agents”) as follows:
PSIVIDA CORP. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • December 20th, 2013 • pSivida Corp. • Laboratory analytical instruments • New York
OMEROS CORPORATION Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • December 14th, 2012 • Omeros Corp • Pharmaceutical preparations • New York
Omeros Corporation, a Washington corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows:
ANTIGENICS INC. 20,000,000 Shares Of Common Stock At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • March 1st, 2010 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • New York
Antigenics Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with McNicoll, Lewis & Vlak LLC, a Delaware limited liability company (“MLV”), and Wm Smith & Co., a Colorado corporation (“Wm Smith” and together with MLV, the “Agents”), as follows:
